RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It operates through the following geographical segments: Switzerland, Europe, North America, and Rest of the World. The company was founded in 2013 and is headquartered in Geneva, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
31
Frequently Asked Questions
What is Market Cap of Relief Therapeutics Holding SA?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Relief Therapeutics Holding SA market cap is $46M.
What is the 52-week high for Relief Therapeutics Holding SA?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Relief Therapeutics Holding SA 52 week high is $7.66 as of September 26, 2025.
What is the 52-week low for Relief Therapeutics Holding SA?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Relief Therapeutics Holding SA 52 week low is $2.25 as of September 26, 2025.
What is Relief Therapeutics Holding SA stock price today?
Relief Therapeutics Holding SA stock price today is $1.93.
What was Relief Therapeutics Holding SA stock price yesterday?
Relief Therapeutics Holding SA stock price yesterday was $1.94.
What is the PE ratio of Relief Therapeutics Holding SA?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Relief Therapeutics Holding SA’s P/E ratio is -2.34.
What is the Price-to-Book ratio of Relief Therapeutics Holding SA?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Relief Therapeutics Holding SA P/B ratio is 1.1212.
What is the 50-day moving average of Relief Therapeutics Holding SA?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Relief Therapeutics Holding SA 50-day moving average is $3.27.
How many employess does Relief Therapeutics Holding SA has?
